Word

NANOPARTICLE DRUG CONJUGATES

Status

Pending

Status Code

645

Status Date

Friday, October 7, 2016

Serial Number

86613156

Mark Type

4000

Filing Date

Tuesday, April 28, 2015

Trademark Owner History

Memorial Sloan Kettering Cancer Center

Classifications

5 pharmaceutical preparations and substances for diagnosis and targeted treatment of cancer and tumor diseases; pharmaceutical preparations and substances for diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; therapeutic agents for diagnosis and targeted treatment of cancer and tumor diseases; therapeutic agents for diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; therapeutic pharmaceuticals and substances for the diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations and substances for diagnosis and treatment of diseases and disorders; therapeutic agents for diagnosis and treatment of diseases and disorders

42 research and development in the fields of pharmaceuticals, biotechnology, therapeutics, and drug formulation and delivery; research and development in the field of targeted therapies for cancer and tumor diseases; research and development in the field of targeted therapies for viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; consulting services in the field of scientific research; consulting services in the field of research and development for pharmaceuticals, biotechnology, therapeutics, and drug formulation and delivery; consulting services in the field of clinical trials; testing, inspection, research, or development of pharmaceutical and therapeutic preparations; pharmaceutical and therapeutic drug development services; pharmaceutical and therapeutic product evaluation; conducting early evaluations in the field of new pharmaceuticals and therapeutics; conducting quality control testing, feasibility testing, toxicology testing and pharmacology testing for pharmaceuticals and therapeutics; laboratory research services relating to pharmaceuticals and therapeutics; medical and scientific research, namely, conducting clinical trials for others; product safety testing for pharmaceuticals and therapeutics

Trademark Events

Oct 7, 2016

Notification Of Final Refusal Emailed

Oct 7, 2016

Final Refusal E-Mailed

Oct 7, 2016

Final Refusal Written

Sep 16, 2016

Teas/Email Correspondence Entered

Sep 16, 2016

Correspondence Received In Law Office

Sep 10, 2016

Assigned To Lie

Sep 2, 2016

Teas Response To Office Action Received

Mar 4, 2016

Notification Of Non-Final Action E-Mailed

Mar 4, 2016

Non-Final Action E-Mailed

Mar 4, 2016

Non-Final Action Written

Feb 12, 2016

Teas/Email Correspondence Entered

Feb 11, 2016

Correspondence Received In Law Office

Feb 11, 2016

Teas Response To Office Action Received

Aug 12, 2015

Notification Of Non-Final Action E-Mailed

Aug 12, 2015

Non-Final Action E-Mailed

Aug 12, 2015

Non-Final Action Written

Aug 6, 2015

Assigned To Examiner

May 9, 2015

New Application Office Supplied Data Entered In Tram

May 1, 2015

New Application Entered In Tram